Evidence map›Paper›PMID 37370267›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Selective Bacteriocins: A Promising Treatment for

Félix Jaumaux, Kenny Petit, Anandi Martin, Hector Rodriguez-Villalobos, Marjorie Vermeersch, David Perez-Morga, Philippe Gabant

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Innovations in process engineering approaches for enhanced bacteriocin production.Journal of industrial microbiology & biotechnology · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Microbisporicin (NAI-107) protectsMicrobiology spectrum · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Félix JaumauxStructure et Fonction des Membranes Biologiques (SFMB), ULB-Campus Plaine Building BC 3rd Floor Wing C, Blvd Triomphe Access 2, 1050 Brussels, Belgium.ORCID 0000-0002-5078-4929
Kenny PetitSyngulon, 1402 Seraing, Belgium.
Anandi MartinSyngulon, 1402 Seraing, Belgium.
Hector Rodriguez-VillalobosCliniques Universitaires Saint-Luc, Avenue Hippocrate 10, 1200 Brussels, Belgium.ORCID 0000-0003-3041-1591
Marjorie VermeerschCenter for Microscopy and Molecular Imaging (CMMI), Université Libre de Bruxelles, Campus de Charleroi-Gosselies (Biopark)-CP 300, Rue Prof. Jeener & Brachet, 12, 6041 Gosselies, Belgium.
David Perez-MorgaCenter for Microscopy and Molecular Imaging (CMMI), Université Libre de Bruxelles, Campus de Charleroi-Gosselies (Biopark)-CP 300, Rue Prof. Jeener & Brachet, 12, 6041 Gosselies, Belgium.ORCID 0000-0002-7168-1865
Philippe GabantSyngulon, 1402 Seraing, Belgium.
Université Libre de Bruxelles · BECliniques Universitaires Saint-Luc · BE

Funding

SPW Recherche (Walloon Region, Belgium) Grant 8065 STAPHCONTROLSPW Recherche (Walloon Region, Belgium) Grant RPR 1920238
6 · The paper itself

Abstract

The emergence of antibiotic-resistant

Indexed as

antibiotic resistanceantimicrobial peptidesbacteriocinscell wall thickeningS. aureusselective inhibitionskin microbiomevancomycinwalK/R two-component system

Identifiers

PMID37370267
PMCPMC10295673
OpenAlexW4378083284

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.